Qingfei Kong

harbin medical university

H指数:30

被引数:2,505

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PEGylated thymosin β4 is a thiol-site-specific prodrug treating myocardial infarction in vivo

PEG化的胸腺肽β4是一种靶向巯基位点的原药，用于体内治疗心肌梗死。

Bioengineering & Translational Medicine

IF5.7

2026-03-310

OAAI

Muscle fiber types switched during the development of experimental autoimmune myasthenia gravis via the PI3K/Akt signaling pathway

实验性自身免疫性重症肌无力发展过程中通过PI3K/Akt信号通路转换的肌纤维类型

MOLECULAR IMMUNOLOGY

IF3

2025-02-010

PRE

Metformin inhibits the pathogenic functions of AChR-specifc B and Th17 cells by targeting miR-146a (vol 250, pg 29, 2022)

二甲双胍通过靶向miR-146a抑制AChR特异性B和Th17细胞的致病功能 (250卷，29页，2022页)

IMMUNOLOGY LETTERS

IF2.8

2024-08-010

PRE

Nucleic acid aptamer-based electrochemical sensor for the detection of serum P-tau231 and the instant screening test of Alzheimer's disease

MICROCHIMICA ACTA

IF5.3

2024-05-142

PRE

3D printing processes in precise drug delivery for personalized medicine

用于个性化医疗的精确药物输送中的3D打印工艺

BIOFABRICATION

IF8

2024-04-1716

OAAI

Impaired cerebral microvascular endothelial cells integrity due to elevated dopamine in myasthenic model

JOURNAL OF NEUROINFLAMMATION

IF10.1

2024-01-041

OAAI

Metformin inhibits the pathogenic functions of AChR-specifc B and Th17 cells by targeting miR-146a (vol 250, pg 29, 2022)

二甲双胍通过靶向miR-146a抑制AChR特异性B和Th17细胞的致病功能 (250卷，29页，2022页)

IMMUNOLOGY LETTERS

IF2.8

2023-11-010

OAAI

DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19

COMPUTERS IN BIOLOGY AND MEDICINE

IF6.3

2023-06-017

OAAI

Metformin inhibits the pathogenic functions of AChR-specific B and Th17 cells by targeting miR-146a

IMMUNOLOGY LETTERS

IF2.8

2022-10-013

PRE

Combining miR-23b exposure with mesenchymal stem cell transplantation enhances therapeutic effects on EAE

IMMUNOLOGY LETTERS

IF2.8

2021-01-018

PREAI

Neural-specific distribution of transmembrane protein TMEM240 and formation of TMEM240-Body

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2020-10-011

PREAI

Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme

FRONTIERS IN ONCOLOGY

IF3.3

2020-09-112

OAAI

MicroRNA-182 exacerbates blood-brain barrier (BBB) disruption by downregulating the mTOR/FOXO1 pathway in cerebral ischemia

FASEB JOURNAL

IF4.2

2020-08-1729

OAAI

Irgm1 knockout indirectly inhibits regeneration after skeletal muscle injury in mice

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2020-07-012

PREAI

Osteopontin exacerbates the progression of experimental autoimmune myasthenia gravis by affecting the differentiation of T cell subsets

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2020-05-017

PREAI

Excess salt intake promotes M1 microglia polarization via a p38/MAPK/AR-dependent pathway after cerebral ischemia in mice

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2020-04-0125

PREAI

Metformin attenuates autoimmune disease of the neuromotor system in animal models of myasthenia gravis

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2019-10-0117

PREAI

Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities

MOLECULAR ONCOLOGY

IF4.5

2019-08-2126

OAAI

Enhancement of T Follicular Helper Cell-Mediated Humoral Immunity Reponses During Development of Experimental Autoimmune Myasthenia Gravis

NEUROSCIENCE BULLETIN

IF5.8

2019-02-2211

OAAI

Functional network analysis reveals biological roles of lncRNAs and mRNAs in MOG35-55 specific CD4+T helper cells

GENOMICS

IF3

2018-11-014

PREAI

Qingfei Kong

个人简介

教育背景

工作经历

荣誉奖项

研究方向